Rob Christiaan van Wijk

16PUBLICATIONS
50CO-AUTHORS
Tissue engineeringMedical mycologyPharmaceutical delivery technologiesGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 25, 2026
Successful Translational Prediction of Bedaquiline's Phase 2a Clinical Trial Results against Tuberculosis: The Zebrafish as a New Approach Methodology.

|Aug 20, 2026
Predicting tuberculosis relapse based on 28-day CFU, RS ratio, and/or drug contribution for novel regimens in the relapsing mouse model.

|Feb 13, 2026
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network.

Priya Jayachandran, Mayur K Ladumor, Georgios Vlasakakis

|Feb 17, 2025
Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models.

Bernard Ngara, Lorenzo Flori, Rob Christiaan van Wijk

|Feb 05, 2025
Selection and prioritization of candidate combination regimens for the treatment of tuberculosis.

Natasha Strydom, Rob C van Wijk, Qianwen Wang

|Sep 28, 2023
Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19.

Rob C van Wijk, Laurynas Mockeliunas, Gerben van den Hoogen

Pageof 3

Frequent Collaborators

6 joint publications

Ulrika S H Simonsson

4 joint publications

Elke H J Krekels

4 joint publications

Radojka M Savic

4 joint publications

Eric Nuermberger